Skip to content

Pfizer CEO Hammered by Drug Regulator for ‘Disgracefully Misleading’ Claims About Covid Vaccines

    Pfizer’s CEO was hammered by a British regulator for making “disgracefully misleading” claims about the Covid mRNA shots also known as “Covid vaccines.”

    UK’s pharmaceutical watchdog, the Prescription Medicines Code of Practice Authority (PMCPA), found that Dr. Albert Bourla, the CEO of Pfizer, made “misleading” statements about healthy children purportedly benefiting from the vaccines.

    In an interview with the BBC last December, Bourla claimed that “there is no doubt in my mind that the benefits, completely, are in favour of” vaccinating children ages five to 11 against Covid-19.

    Bourla argued that “Covid in schools is thriving,” adding: “This is disturbing, significantly, the educational system, and there are kids that will have severe symptoms.”

    After the interview was published on December 2, prior to the approval of the vaccine for the age group in question, UsForThem, a parent watchdog group defending children’s rights throughout the Covid pandemic, submitted a complaint to the Prescription Medicines Code of Practice Authority (PMCPA).

    The complaint substantiated that Dr. Bourla made “disgracefully misleading” remarks about the Covid shots that were “extremely promotional in nature.” The complaint argued that his remarks breached multiple clauses of the Association of the British Pharmaceutical Industry’s (ABPI) code of practice.

    “There is simply no evidence that healthy schoolchildren in the UK are at significant risk from the SARS COV-2 virus and to imply that they are is disgracefully misleading,” the group said.

    Pfizer appealed the drug regulator’s findings by arguing its claims were based on “up-to-date scientific evidence” that could be substantiated by the “publicly available independent benefit-risk assessments”.

    The pharmaceutical watchdog upheld that Dr. Bourla committed several ethical breaches, including having misled the public, made unsubstantiated claims, and showed a lack of balance.

    PMCPA said the full case report on Pfizer’s ethical misconduct will be published in the coming weeks.

    NOW READ:

    Moderna CEO Compares Annual Covid-19 ‘Boosters’ to Seasonal Flu Shots, Advocates Them for the Elderly and At-Risk

    "*" indicates required fields

    Who's your favorite former President?*
    This poll gives you free access to our premium politics newsletter. Unsubscribe at any time.
    This field is for validation purposes and should be left unchanged.





    OPINION: This article contains commentary which reflects the author's opinion.